Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms

The Pharmacological Basis of Therapeutics

(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 9,216 · see citing works

Identification and characterization of a spinal muscular atrophy-determining gene

Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Bénichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,995 · see citing works

Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6

Vance, C. A., Rogelj, B., Hortobágyi, T., Vos, K. J. D., Nishimura, A. L., Sreedharan, J., Hu, X., Smith, B. N., Ruddy, D., Wright, P. D., et al. (2009) · Science · doi:10.1126/science.1165942 · Cited by 2,531 · see citing works

Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis

Kwiatkowski, T. J., Bosco, D. A., LeClerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J. M., Kasarskis, E. J., Munsat, T. L., et al. (2009) · Science · doi:10.1126/science.1166066 · Cited by 2,526 · see citing works

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,211 · see citing works

A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy

Lorson, C. L., Hahnen, E., Androphy, E. J., & Wirth, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6307 · Cited by 1,536 · see citing works

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · see citing works

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., & Kaspar, B. K. (2009) · Nature Biotechnology · doi:10.1038/nbt.1515 · Cited by 1,456 · see citing works

Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections

Nau, R., Sörgel, F., & Eiffert, H. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00007-10 · Cited by 1,031 · see citing works

A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2

Monani, U. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.7.1177 · Cited by 951 · see citing works

The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy

Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 732 · see citing works

Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?

Burghes, A. H. M., & Beattie, C. E. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2670 · Cited by 723 · see citing works

Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos

Schrank, B., Götz, R., Gunnersen, J. M., Ure, J., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661 · see citing works

Smn, the spinal muscular atrophy–determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons

Rossoll, W., Jablonka, S., Andreassi, C., Kröning, A.-K., Karle, K. N., Monani, U. R., & Sendtner, M. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200304128 · Cited by 637 · see citing works

Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.

Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623 · see citing works

SMN Deficiency Causes Tissue-Specific Perturbations in the Repertoire of snRNAs and Widespread Defects in Splicing

Zhang, Z., Lotti, F., Dittmar, K. A., Younis, I., Wan, L., Kasim, M., & Dreyfuss, G. (2008) · Cell · doi:10.1016/j.cell.2008.03.031 · Cited by 610 · see citing works

SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN

Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 600 · see citing works

Essential Role for the SMN Complex in the Specificity of snRNP Assembly

Pellizzoni, L., Yong, J., & Dreyfuss, G. (2002) · Science · doi:10.1126/science.1074962 · Cited by 544 · see citing works

Plastin 3 Is a Protective Modifier of Autosomal Recessive Spinal Muscular Atrophy

Oprea, G. E., Kröber, S., McWhorter, M. L., Rossoll, W., Müller, S., Krawczak, M., Bassell, G. J., Beattie, C. E., & Wirth, B. (2008) · Science · doi:10.1126/science.1155085 · Cited by 496 · see citing works

Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis

Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479 · see citing works

The Pharmacological Basis of Therapeutics.

Gemmill, C. L. (1966) · Journal of Medicinal Chemistry · doi:10.1021/jm00324a062 · Cited by 439 · see citing works

Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy

Brichta, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg256 · Cited by 382 · see citing works

Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number

Wirth, B., Brichta, L., Schrank, B., Lochmüller, H., Blick, S., Baasner, A.-L., & Heller, R. (2006) · Human Genetics · doi:10.1007/s00439-006-0156-7 · Cited by 355 · see citing works

Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy

Avila, A. M., Burnett, B. G., Taye, A. A., Gabanella, F., Knight, M. A., Hartenstein, P., Cizman, Z., Prospero, N. A. D., Pellizzoni, L., Fischbeck, K. H., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29562 · Cited by 350 · see citing works

Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes

Lee, S., Su, Z. Z., Emdad, L., Gupta, P., Sarkar, D., Borjabad, A., Volsky, D. J., & Fisher, P. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707697200 · Cited by 318 · see citing works

Ribonucleoprotein Assembly Defects Correlate with Spinal Muscular Atrophy Severity and Preferentially Affect a Subset of Spliceosomal snRNPs

Gabanella, F., Butchbach, M. E. R., Saieva, L., Carissimi, C., Burghes, A. H. M., & Pellizzoni, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000921 · Cited by 315 · see citing works

Valproic acid increases SMN levels in spinal muscular atrophy patient cells

Sumner, C. J., Huynh, T. N., Markowitz, J. A., Perhac, J. S., Hill, B. J., Coovert, D. D., Schussler, K. R., Chen, X., Jarecki, J., Burghes, A. H. M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10743 · Cited by 289 · see citing works

When Is a Deletion Not a Deletion? When It Is Converted

Burghes, A. H. M. (1997) · The American Journal of Human Genetics · doi:10.1086/513913 · Cited by 278 · see citing works

Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy

Andreassi, C., Angelozzi, C., Tiziano, F. D., Vitali, T., Vincenzi, E. D., Boninsegna, A., Villanova, M., Bertini, E., Pini, A., Neri, G., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201102 · Cited by 254 · see citing works

Spinal muscular atrophy: mechanisms and therapeutic strategies

Lorson, C. L., Rindt, H., & Shababi, M. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq147 · Cited by 209 · see citing works

Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy

Azzouz, M., Le, T. T., Ralph, G. S., Walmsley, L. E., Monani, U. R., Lee, D. C. P., Wilkes, F. J., Mitrophanous, K. A., Kingsman, S. M., Burghes, A. H. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22922 · Cited by 209 · see citing works

Fimbrin is a cytoskeletal protein that crosslinks F-actin in vitro.

Bretscher, A. P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6849 · Cited by 201 · see citing works

Multiprotein Complexes of the Survival of Motor Neuron Protein SMN with Gemins Traffic to Neuronal Processes and Growth Cones of Motor Neurons

Zhang, H., Xing, L., Rossoll, W., Wichterle, H., Singer, R. H., & Bassell, G. J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3967-05.2006 · Cited by 200 · see citing works

Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS

Kirby, J., Halligan, E. P., Baptista, M. J., Allen, S., Heath, P. R., Holden, H. M., Barber, S. C., Loynes, C. A., Wood-Allum, C. A., Lunec, J., et al. (2005) · Brain · doi:10.1093/brain/awh503 · Cited by 200 · see citing works

Higher order arrangement of the eukaryotic nuclear bodies

Wang, I., Reddy, N. M., & Shen, C.-K. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212483099 · Cited by 190 · see citing works

The Survival of Motor Neurons Protein Determines the Capacity for snRNP Assembly: Biochemical Deficiency in Spinal Muscular Atrophy

Wan, L., Battle, D. J., Yong, J., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5543-5551.2005 · Cited by 187 · see citing works

The Genetic Component in Child Mortality

Roberts, D. F., Chavez, J., & Court, S. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.239.33 · Cited by 175 · see citing works

Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxonein vitro

Lewerenz, J., Albrecht, P., Tien, M. T., Henke, N., Karumbayaram, S., Kornblum, H. I., Wiedau‐Pazos, M., Schubert, D., Maher, P. A., & Methner, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06347.x · Cited by 174 · see citing works

TDP-43 Overexpression Enhances Exon 7 Inclusion during the Survival of Motor Neuron Pre-mRNA Splicing

Bose, J. K., Wang, I., Li, H., Tarn, W., & Shen, C. ‐. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805376200 · Cited by 172 · see citing works

Why do cells need an assembly machine for RNA–protein complexes?

Yong, J., Wan, L., & Dreyfuss, G. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2004.03.010 · Cited by 167 · see citing works

The role of histone acetylation in SMN gene expression

Kernochan, L. E., Russo, M. L., Woodling, N. S., Huynh, T. N., Avila, A. M., Fischbeck, K. H., & Sumner, C. J. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi130 · Cited by 164 · see citing works

The role of the SMN gene in proximal spinal muscular atrophy

Lefebvre, S. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.10.1531 · Cited by 154 · see citing works

Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy

Corti, S. P., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Ronchi, D., Saladino, F., Bordoni, A., Fortunato, F., Bo, R. D., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35432 · Cited by 142 · see citing works

A Phase 1 Trial of Riluzole in Spinal Muscular Atrophy

Russman, B. S., Iannaccone, S. T., & Samaha, F. J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.11.1601 · Cited by 133 · see citing works

SMN, profilin IIa and plastin 3: A link between the deregulation of actin dynamics and SMA pathogenesis

Bowerman, M., Anderson, C. L., Beauvais, A., et al. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.05.009 · Cited by 131 · see citing works

Regular Exercise Prolongs Survival in a Type 2 Spinal Muscular Atrophy Model Mouse

Grondard, C., Biondi, O., Armand, A., Lécolle, S., Gaspera, B. D., Pariset, C. C., Li, H., Gallien, C., Vidal, P., Chanoine, C., et al. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1245-05.2005 · Cited by 127 · see citing works

Cloning, Characterization, and Copy Number of the Murine Survival Motor Neuron Gene: Homolog of the Spinal Muscular Atrophy-Determining GenePreprint

DiDonato, C. J., Chen, X., Noya, D., Korenberg, J. R., Nadeau, J. H., & Simard, L. R. (1997) · Genome Research · doi:10.1101/gr.7.4.339 · Cited by 119 · see citing works

Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy

Rudnik‐Schöneborn, S., Goebel, H., Schlote, W., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000052788.39340.45 · Cited by 117 · see citing works

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy

Butchbach, M. E. R., Edwards, J. D., & Burghes, A. H. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.009 · Cited by 110 · see citing works

Identification of a battery of tests for drug candidate evaluation in the SMNΔ7 neonate model of spinal muscular atrophy

El‐Khodor, B. F., Edgar, N. M., Chen, A., Winberg, M. L., Joyce, C. L., Brunner, D., Suárez‐Fariñas, M., & Heyes, M. P. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.02.025 · Cited by 101 · see citing works

Abolishing Bax-Dependent Apoptosis Shows Beneficial Effects on Spinal Muscular Atrophy Model Mice

Tsai, M., Chiu, Y. T., Wang, S. H., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.02.008 · Cited by 48 · see citing works

Motoneuron Transplantation Rescues the Phenotype of SMARD1 (Spinal Muscular Atrophy with Respiratory Distress Type 1)

Corti, S. P., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Bo, R. D., Papadimitriou, D. A., Locatelli, F., Mezzina, N., Gianni, F., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2734-09.2009 · Cited by 39 · see citing works

Valproic acid blocks excitability in SMA type I mouse motor neurons

ten Rak, K., Lechner, B. D., Schneider, C. B., Drexl, H., Sendtner, M., & Jablonka, S. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.08.014 · Cited by 27 · see citing works

Possible strategies for treatment of SMA patients: A neurobiologist's view

Greensmith, L., & Vrbovà, G. (1995) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)00090-v · Cited by 21 · see citing works

Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN

Olaso, R., Joshi, V., Fernández, J. G., et al. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00134.2005 · Cited by 20 · see citing works

Perspectives on models of spinal muscular atrophy for drug discovery

Butchbach, M. E. R., & Burghes, A. H. M. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.07.001 · Cited by 17 · see citing works

Histologic and transcriptional assessment of a mild SMA model

Balabanian, S., Gendron, N. H., & Mackenzie, A. E. (2007) · Neurological Research · doi:10.1179/016164107x159243 · Cited by 16 · see citing works

The Time to Demand Funding

Mello, C. C., & Walsh, J. V. (2009) · Science · doi:10.1126/science.323.5911.208a · Cited by 1 · see citing works

Neuroprotective Effect of Ceftriaxone on MPTP‐Induced Parkinson’s Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota

Zhou, X., Lu, J., Wei, K., Wei, J., Tian, P., Yue, M., Wang, Y., Hong, D., Li, F., Wang, B., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9424582 · Cited by 85 · see citing works

Ceftriaxone Prevents and Reverses Behavioral and Neuronal Deficits in an MPTP-Induced Animal Model of Parkinson’s Disease Dementia

Hsu, C.-Y., Hung, C.-S., Chang, H.-M., Liao, W.-C., Ho, S.-C., & Ho, Y.-J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.023 · Cited by 63 · see citing works

Ceftriaxone Prevents the Neurodegeneration and Decreased Neurogenesis Seen in a Parkinson’s Disease Rat Model: An Immunohistochemical and MRI Study

Weng, J.-C., Tikhonova, M. A., Chen, J.-H., Shen, M.-S., Meng, W.-Y., Chang, Y.-T., Chen, K.-H., Liang, K.-C., Hung, C.-S., Amstislavskaya, T. G., et al. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.02.034 · Cited by 39 · see citing works

Ceftriaxone Reverses Deficits of Behavior and Neurogenesis in an MPTP-Induced Rat Model of Parkinson’s Disease Dementia

Hsieh, M.-H., Meng, W.-Y., Liao, W.-C., Weng, J.-C., Li, H.-H., Su, H.-L., Lin, C.-L., Hung, C.-S., & Ho, Y.-J. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.05.015 · Cited by 35 · see citing works

Alterations in Neuronal Survival and Glial Reactions after Axotomy by Ceftriaxone and Minocycline in the Mouse Hypoglossal Nucleus

Yamada, J., & Jinno, S. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.051 · Cited by 21 · see citing works

Perspectives on models of spinal muscular atrophy for drug discovery

Butchbach, M. E. R., & Burghes, A. H. M. (2004) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2004.07.001 · Cited by 17 · see citing works

Efficacy and safety of nusinersen in children with later-onset spinal muscular atrophy (SMA): results of the phase 3 CHERISH study

Kirschner, J., Mercuri, E. M., Finkel, R. S., et al. (2017) · Neuropediatrics · doi:10.1055/s-0037-1603574 · Cited by 1 · see citing works

Recent research on the treatment of spinal muscular atrophy.

Yang, D. (2022) · PubMed · doi:10.7499/j.issn.1008-8830.2110041 · Cited by 2 · see citing works

Therapeutic decisions under uncertainty in spinal muscular atrophy (decisions-SMA study): A research protocol

Saposnik, G., Díaz-Abós, P., Sánchez-Menéndez, V., et al. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.118428

P.362RAINBOWFISH: A study of risdiplam (RG7916) in newborns with pre-symptomatic spinal muscular atrophy (SMA)

Bertini, E., Day, J., Muhaizea, M., et al. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.06.524 · Cited by 8 · see citing works